SGX

DEAD

Serial Number

76480945

Owner

SGX PHARMACEUTICALS, INC.

Attorney

Kent M. Walker, Esq.

First Use Date

Aug 30, 2005

Filing Date

Jan 7, 2003

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SGX Trademark

Serial Number: 76480945 • Registration: 3527863

SGX is a trademark filed by SGX PHARMACEUTICALS, INC. on January 7, 2003. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 9 - Computers & Electronics

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Owner Contact Info

SGX PHARMACEUTICALS, INC. (4 trademarks)

10505 ROSELLE STREET
SAN DIEGO, CA 92121

Entity Type: 03

Structural Genomix, Inc. (4 trademarks)

10505 Roselle
San Diego, CA 92121

Entity Type: 03

Legal Representation

Attorney of Record

Kent M. Walker, Esq.

89 trademarks filed View all →

Trademark Details

Filing Date

January 7, 2003

Registration Date

November 4, 2008

First Use Anywhere

August 30, 2005

First Use in Commerce

August 30, 2005

Published for Opposition

October 12, 2004

Cancellation Date

June 5, 2015

Goods & Services

Computer software for graphic modeling and display of protein structures and parts thereof; computer software for screening, identifying, and designing ligands in the field of drug discovery; computer software for identifying and designing DNA and protein sequences for use in protein structure determination; laboratory devices, namely, automated robots for use in protein structure determination; crystallization devices, namely, crystallization receptacles; beamline devices, namely, crystal handlings devices for use in an X-ray beam; and sample handling devices, namely, cystallization trays and sonicators

Pharmaceutical preparations, namely, agents for the treatment of infectious diseases, immune system disorders, allergic disorders, cardiovascular disorders, pulmonary disorders, gastrointestinal disorders, hepatic and biliary disorders, nutritional and metabolic disorders, endocrine disorders, hematological and oncological disorders, inflammatory conditions, gynecological disorders, obstetric conditions, musculoskeletal and connective tissue disorders, neurologic disorders, psychiatric disorders, genitourinary disorders, pediatric conditions, otolaryngological disorders, ophthalmologic disorders, dermatologic disorders, dental and oral disorders, disorders due to physical agents, poisoning, venomous bites and stings; for organ and tissue preservation and transplantation; for bone marrow transplantation; and nutritional supplements; biological proteins for therapeutic uses in the clinical medical field

Biological proteins for scientific research use; protein structure determination products, namely, DNA clones designed to express proteins for crystallization for scientific use

Filing History

CANCELLED SEC. 8 (6-YR)

Jun 5, 2015 C8..

REGISTERED-PRINCIPAL REGISTER

Nov 4, 2008 R.PR

LAW OFFICE REGISTRATION REVIEW COMPLETED

Sep 30, 2008 REGV

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 29, 2008 CNPR

EXAMINER'S AMENDMENT ENTERED

Sep 12, 2008 XAEC

ASSIGNED TO LIE

Sep 11, 2008 ALIE

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 10, 2008 GNEN

EXAMINERS AMENDMENT E-MAILED

Sep 10, 2008 GNEA

SU-EXAMINER'S AMENDMENT WRITTEN

Sep 10, 2008 SNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 20, 2008 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 20, 2008 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 20, 2008 TROA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Feb 25, 2008 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Feb 25, 2008 REAP

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 20, 2008 GNRN

NON-FINAL ACTION E-MAILED

Feb 20, 2008 GNRT

SU - NON-FINAL ACTION - WRITTEN

Feb 20, 2008 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Jan 30, 2008 SUPC

USE AMENDMENT FILED

Dec 21, 2007 IUAF

TEAS STATEMENT OF USE RECEIVED

Dec 21, 2007 EISU

SOU EXTENSION 5 GRANTED

Sep 9, 2007 EX5G

SOU EXTENSION 5 FILED

Jul 3, 2007 EXT5

SOU TEAS EXTENSION RECEIVED

Jul 3, 2007 EEXT

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 3, 2007 TCCA

SOU EXTENSION 4 GRANTED

Feb 22, 2007 EX4G

SOU EXTENSION 4 FILED

Dec 18, 2006 EXT4

SOU TEAS EXTENSION RECEIVED

Dec 18, 2006 EEXT

SOU EXTENSION 3 GRANTED

May 24, 2006 EX3G

SOU EXTENSION 3 FILED

May 24, 2006 EXT3

SOU TEAS EXTENSION RECEIVED

May 24, 2006 EEXT

SOU EXTENSION 2 GRANTED

Dec 21, 2005 EX2G

SOU EXTENSION 2 FILED

Dec 21, 2005 EXT2

SOU TEAS EXTENSION RECEIVED

Dec 21, 2005 EEXT

SOU EXTENSION 1 GRANTED

Mar 9, 2005 EX1G

DIVISIONAL PROCESSING COMPLETE

Mar 9, 2005 DPCC

SOU EXTENSION 1 FILED

Feb 10, 2005 EXT1

DIVISIONAL REQUEST RECEIVED

Feb 10, 2005 DRRR

PAPER RECEIVED

Feb 10, 2005 MAIL

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 20, 2005 TCCA

NOA MAILED - SOU REQUIRED FROM APPLICANT

Jan 4, 2005 NOAM

PUBLISHED FOR OPPOSITION

Oct 12, 2004 PUBO

NOTICE OF PUBLICATION

Sep 22, 2004 NPUB

LAW OFFICE PUBLICATION REVIEW COMPLETED

Aug 11, 2004 PREV

ASSIGNED TO LIE

Aug 4, 2004 ALIE

ASSIGNED TO LIE

Aug 3, 2004 ALIE

ASSIGNED TO LIE

Jul 29, 2004 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 28, 2004 CNSA

AMENDMENT FROM APPLICANT ENTERED

Jul 16, 2004 ACEC

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 16, 2004 CRFA

PAPER RECEIVED

Jul 16, 2004 MAIL

FINAL REFUSAL MAILED

Jan 16, 2004 CNFR

CASE FILE IN TICRS

Oct 23, 2003 CFIT

PAPER RECEIVED

Sep 22, 2003 MAIL

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 18, 2003 CRFA

NON-FINAL ACTION MAILED

Mar 18, 2003 CNRT

ASSIGNED TO EXAMINER

Mar 14, 2003 DOCK

Related Trademarks

More from this Owner

SGX PHARMACEUTICALS

E SGX

More in Same Class

MEDMIRA

WEEDPREVENT

PURE ICE

BIOSENSE LABORATORIES

SYNPHOS

HUBERDERM